March 26, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
Biotricity combines real-time heart monitoring with mobile telemetry to bridge the gap between remote monitoring and chronic care management. It’s an important breakthrough that is gaining momentum. Sales more than doubled from December 2019 to December 2020.
The Bioflux Active Heart Monitor:
- Runs on proprietary, FDA-cleared software with advanced beat and arrhythmia autodetection
- Monitors and records ECG Data for up to 30 days
- Up to 1000 samples per second for unparalleled clinical precision
- Sends encrypted data directly to clinic with programmable auto-triggers for bradycardia, tachycardia, asystole, and atrial fibrillation
Join us on March 26 to hear from Biotricity Co-Founder and CEO, Waqaas Al-Siddiq to learn how patients, physicians, and payers will all benefit from this revolutionary new device.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.